smithklin ltskb aim 10 pct earn rais smithklin beckman corp pursu threepoint stragey achiev 10 pct annual increas oper earn remaind decad 1986 smithklin earn 5211 mln dlr 678 dlr share revenu 36 billion dlr compani annual report nonpharmaceut busi play major role meet earn growth target fact grow faster pharmaceut busi smithklin major product antiulc medic tagamet report intend improv earn exist product expand product portfolio optim financi resourc bolster posit antiulc market tagamet ha met stiff competit smithklin strategi develop overthecount version tagamet bolster joint ventur ltwellcom plc pend ventur japan smithklin allergan eye skin care product divis billion dlr organ year grow 10 pct annual nondilut acquisit real possibl gavin herbert presid eye skin care product group report 1986 allergan worldwid sale 433 mln dlr smith kline french laboratori pharmaceut unit 1986 sale 19 billion dlr file food drug administr market approv number cardiovascular agent includ tissu plasminogen activ year sk fs sale forc 20 pct larger 1987 1000 sale personnel smith kline small clinic laboratori test unit 1986 sale 373 mln dlr perform 24 mln test year increas employe drug test test aid antibodi smith kline depend share price cost money buy back share year ha bought back 25 pct share smithklin begin year manag team includ chief oper offic georg ebright